We are live on ! Find out more
ADPT icon

Adaptive Biotechnologies
ADPT

209 hedge funds and large institutions have $1.08B invested in Adaptive Biotechnologies in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 88 increasing their positions, 58 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

289% more call options, than puts

Call options by funds: $1.62M | Put options by funds: $417K

52% more repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 58

5.66% more ownership

Funds ownership: 88.71% → 94.37% (+5.7%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less funds holding

Funds holding: 221 → 209 (-12)

25% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 40

38% less capital invested

Capital invested by funds: $1.74B → $1.08B (-$657M)

Holders
209
Holders Change
-12
Holders Change %
-5.43%
% of All Funds
3.52%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
30
Increased
88
Reduced
58
Closed
40
Calls
$1.62M
Puts
$417K
Net Calls
+$1.21M
Net Calls Change
+$2.11M

Top Buyers

1
BWLSA
Blue Water Life Science Advisors
California
+$27.4M
2
BlackRock
BlackRock
New York
+$26.9M
3
AIM
ARK Investment Management
Florida
+$9.35M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$7.4M
5
Principal Financial Group
Principal Financial Group
Iowa
+$6.02M

Top Sellers

1
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$17.9M
2
CC
Casdin Capital
New York
-$13.9M
3
TCM
TimesSquare Capital Management
New York
-$10.9M
4
Ameriprise
Ameriprise
Minnesota
-$9M
5
TM
Tiger Management
New York
-$8.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$5.25M +$2.7M +306,982 +90%
Balyasny Asset Management
27
Balyasny Asset Management
Illinois
$5M +$5.44M +618,658 New
JP Morgan Chase
28
JP Morgan Chase
New York
$4.54M +$2.04M +231,673 +70%
Neuberger Berman Group
29
Neuberger Berman Group
New York
$4.2M -$6.59M -749,517 -59%
Renaissance Technologies
30
Renaissance Technologies
New York
$3.94M +$272K +30,900 +7%
N
31
Nuveen
North Carolina
$3.52M +$965K +109,768 +34%
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$3.36M -$417K -47,440 -10%
Citadel Advisors
33
Citadel Advisors
Florida
$3.25M +$1.76M +199,698 +99%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$3.07M -$4.63M -526,335 -58%
Lazard Asset Management
35
Lazard Asset Management
New York
$2.93M +$1.1M +124,864 +53%
PC
36
Pier Capital
Connecticut
$2.74M -$6.61K -752 -0.2%
TCM
37
Tekla Capital Management
Massachusetts
$2.73M – – –
TM
38
Triatomic Management
California
$2.67M +$290K +32,933 +11%
CSS
39
Cubist Systematic Strategies
Connecticut
$2.57M +$65.7K +7,477 +2%
Two Sigma Investments
40
Two Sigma Investments
New York
$2.44M +$1.48M +168,388 +126%
PAMS
41
Pictet Asset Management (Switzerland)
Switzerland
$2.39M +$1.32M +150,154 +103%
State of New Jersey Common Pension Fund D
42
State of New Jersey Common Pension Fund D
New Jersey
$2.38M +$956K +108,686 +58%
PIM
43
Platinum Investment Management
Australia
$2.38M +$1.31M +149,494 +103%
PCM
44
Peregrine Capital Management
Minnesota
$2.38M -$213K -24,192 -8%
AG
45
Algert Global
California
$2.36M +$1.6M +181,559 +165%
Thrivent Financial for Lutherans
46
Thrivent Financial for Lutherans
Minnesota
$2.22M -$160K -18,196 -6%
LCM
47
Landscape Capital Management
New Jersey
$2.18M +$814K +92,583 +53%
FCM
48
Frontier Capital Management
Massachusetts
$1.9M -$3.18M -362,228 -61%
Carson Wealth (CWM LLC)
49
Carson Wealth (CWM LLC)
Nebraska
$1.9M -$305K -34,676 -13%
Swiss National Bank
50
Swiss National Bank
Switzerland
$1.89M +$146K +16,600 +8%
1
2
3 4 5

ADPT Hedge Fund Activity: Q2 2022 in Review

209 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q2 2022, worth a combined $1.08B — down 38% from $1.74B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of ADPT and 30 opened new positions — a net loss of 10 holders — while 58 trimmed existing stakes and 88 added.

The largest buyer was Blue Water Life Science Advisors, opening a new position worth an estimated $27.4M. The largest seller was Massachusetts Financial Services, cutting an estimated $17.9M.

  • 209 institutional investors held Adaptive Biotechnologies (ADPT) as of Q2 2022, down from 221 in Q1 2022.
  • Funds reported $1.08B of Adaptive Biotechnologies stock for Q2 2022, down 38% quarter-over-quarter.
  • 30 funds opened new Adaptive Biotechnologies positions in Q2 2022 and 40 closed out, a net change of -10 holders.
  • The largest Adaptive Biotechnologies buyer in Q2 2022 was Blue Water Life Science Advisors, an estimated $27.4M added.
  • The largest Adaptive Biotechnologies seller in Q2 2022 was Massachusetts Financial Services, an estimated $17.9M sold.

Based on aggregated 13F filings for Q2 2022.